By blood proteomic analysis, researchers found that AMBP, α2 macroglobulin, and SERPINA1 might be valuable biomarkers for early detection of lung cancer using serum from 20 NSCLC and 10 healthy donors [33], and it would be better to perform a clinical validation in a larger cohort. This evidence concerns the gene SERPINA1 and lung cancer.